Publications by authors named "Ronald DeConti"

Claim this Profile
L
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.
Mark B Faries, Nicola Mozzillo, Mohammed Kashani-Sabet, John F Thompson, Mark C Kelley, Ronald C DeConti

Ann Surg Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy.
Sarah Sloot, Jonathan S Zager, Ragini R Kudchadkar, Jane L Messina, Jacob J Benedict, Ronald DeConti

Melanoma Res· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma.
Franz O Smith, Binglin Yue, Suroosh S Marzban, Brooke L Walls, Michael Carr, Ronald C DeConti

Cancer· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.
Tawee Tanvetyanon, Tapan Padhya, Judith McCaffrey, Julie A Kish, Ronald C Deconti

Head Neck· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma.
Geoffrey T Gibney, Ragini R Kudchadkar, Ronald C DeConti, Melissa S Thebeau, Maria P Czupryn

Clin Cancer Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma.
James T May, Nikhil Rao, Roberto D Sabater, Hinda Boutrid, Jimmy J Caudell, Ronald Deconti

Head Neck· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Squamous cell carcinoma with rhabdoid phenotype of skin/soft tissue in a transplant patient: an exceptional case and review of the literature.
Pushpa Allam-Nandyala, Marilyn M Bui, Ronald DeConti, Chetna Purohit, Soner Altiok

Diagn Cytopathol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction: Advanced cutaneous malignancies.
L Frank Glass, Ronald C DeConti, Vernon K Sondak

Semin Oncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy of squamous cell carcinoma of the skin.
Ronald C DeConti

Semin Oncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinoma.
Sreekanth Donepudi, Ronald C DeConti, Wolfram E Samlowski

Semin Oncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).
Athanassios Argiris, Musie Ghebremichael, Barbara Burtness, Rita S Axelrod, Ronald C Deconti

Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331).
Wolfram E Samlowski, James Moon, Ralph J Tuthill, Michael C Heinrich, Naomi S Balzer-Haas, Ronald C DeConti

Am J Clin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in dendritic cell phenotype after a new high-dose weekly schedule of interleukin-2 therapy for kidney cancer and melanoma.
Steven E Finkelstein, Timothy Carey, Ingo Fricke, Daohai Yu, Dawn Goetz, Ronald DeConti

J Immunother· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic treatments for merkel cell carcinoma.
Ragini Kudchadkar, Ronald Deconti

Curr Probl Cancer· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma.
Tawee Tanvetyanon, Dahui Qin, Tapan Padhya, Judith McCaffrey, Weiwei Zhu, Ronald DeConti

Arch Otolaryngol Head Neck Surg· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for survival after salvage reirradiation of head and neck cancer.
Tawee Tanvetyanon, Tapan Padhya, Judith McCaffrey, Weiwei Zhu, David Boulware, Ronald Deconti

J Clin Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiation of a topoisomerase I inhibitor, karenitecin, by the histone deacetylase inhibitor valproic acid in melanoma: translational and phase I/II clinical trial.
Adil I Daud, Jana Dawson, Ronald C DeConti, Elona Bicaku, Douglas Marchion

Clin Cancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
Adil I Daud, Ronald C DeConti, Stephanie Andrews, Patricia Urbas, Adam I Riker

J Clin Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor.
Adil I Daud, Noweeda Mirza, Brianna Lenox, Stephanie Andrews, Patricia Urbas, Ronald C Deconti

J Clin Oncol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study.
Pamela Münster, Douglas Marchion, Elona Bicaku, Morgen Schmitt, Ji Hyun Lee, Ronald DeConti

J Clin Oncol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
Malcolm S Mitchell, Judith Abrams, John A Thompson, Mohammed Kashani-Sabet, Ronald C DeConti

J Clin Oncol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
Agop Y Bedikian, Michael Millward, Hubert Pehamberger, Robert Conry, Martin Gore, Ronald DeConti

J Clin Oncol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival after surgical resection of isolated pulmonary metastases from malignant melanoma.
Stephanie Andrews, Lary Robinson, Alan Cantor, Ronald C DeConti

Cancer Control· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
Michael K Gibson, Yi Li, Barbara Murphy, Maha H A Hussain, Ronald C DeConti

J Clin Oncol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of karenitecin in patients with malignant melanoma: clinical and translational study.
Adil Daud, Nikola Valkov, Barbara Centeno, Jennifer Derderian, Patricia Sullivan, Ronald C Deconti

Clin Cancer Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis